Tel Aviv, Israel; June 7, 2022: Following US Food and Drug Administration (FDA) clearance of the MeMed BV® test, which helps physicians distinguish between bacterial and viral infections in just 15 ...
A new host-response blood test from Beckman Coulter and MeMed delivers bacterial-vs-viral results in 15 minutes, aiding ...
– Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management – – MeMed and Physicians Premier Celebrated Milestone Event in Corpus Christi, Texas – ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The FDA granted clearance to a rapid blood test designed to distinguish between bacterial and viral infections in as little ...
Newswise — Saluggia, July 22, 2022 - DiaSorin (FTSE MIB: DIA) announced today the FDA 510(k) clearance and the commercial launch in the US of the host-protein signature-based assay LIAISON® MeMed BV® ...
Beckman Coulter Diagnostics has obtained a European CE mark for the use of its laboratory test designed to distinguish between bacterial and viral infections within 20 minutes. The Danaher company's ...
ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)-- MeMed, a global leader in host-response diagnostics, today announced a major milestone: more than 100,000 patients have now been tested with MeMed BV® ...
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing "By delivering rapid, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results